0001203311-15-000042.txt : 20150825
0001203311-15-000042.hdr.sgml : 20150825
20150825203008
ACCESSION NUMBER: 0001203311-15-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150820
FILED AS OF DATE: 20150825
DATE AS OF CHANGE: 20150825
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIMES VAUGHN B
CENTRAL INDEX KEY: 0001361966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 151074509
MAIL ADDRESS:
STREET 1: C/O SEATTLE GENETICS, INC.
STREET 2: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-08-20
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001361966
HIMES VAUGHN B
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
EVP, Proc Svcs & Tech Ops
Common Stock
2015-08-20
4
S
0
5997.0
42.0245
D
61212
D
Common Stock
2015-08-25
4
A
0
15000.0
0.0
A
76212
D
Incentive Stock Option (right to buy)
39.15
2015-08-25
4
A
0
2554.0
0.0
A
2025-08-25
Common Stock
2554
2554
D
Non-Qualified Stock Option (right to buy)
39.15
2015-08-25
4
A
0
34946.0
0.0
A
2025-08-25
Common Stock
34946
34946
D
Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
These shares represent restricted stock units and will be settled in common stock upon vesting.
Restricted stock units shall vest in full three (3) years from grant date.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years from grant date.
Vaughn B. Himes
2015-08-25